| Sources | Names Used |
|---|---|
| GDSC1000 | THZ-2-102-1 |
| PharmacoGx | THZ-2-102-1 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABCG2 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-17 |
| mRNA | MYOF | GDSC1000 | pan-cancer | AAC | -0.34 | 3e-17 |
| mRNA | SDC4 | GDSC1000 | pan-cancer | AAC | -0.34 | 5e-16 |
| mRNA | ABCC3 | GDSC1000 | pan-cancer | AAC | -0.28 | 2e-15 |
| mRNA | NQO1 | GDSC1000 | pan-cancer | AAC | -0.29 | 5e-14 |
| mRNA | ILF3 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-13 |
| mRNA | LGALS3 | GDSC1000 | pan-cancer | AAC | -0.25 | 8e-13 |
| mRNA | ASPH | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-12 |
| mRNA | MVP | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-12 |
| mRNA | SQSTM1 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-12 |
